Pasco, Vincent B.
HRN: 21-69-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2024
MUPIROCIN 2%, 15G (TUBE)
08/23/2024
08/28/2024
TOPICAL
As Needed
BID
Skin Lesions
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes